Science
Mechanism of Action
On a cellular level, Decursinol exhibits neuroprotective effects by decreasing glutamate-induced intracellular calcium levels and enhancing cellular antioxidant defenses through the preservation of glutathione and glutathione peroxidase activity, thereby reducing peroxide production. Although primarily studied for its systemic influence on central nervous system receptors for pain relief, its potential topical mechanism for skin would likely leverage these observed antioxidant capacities to mitigate oxidative stress and offer cellular protection. However, specific direct mechanisms of action relating to human skin benefits for cosmetic purposes are not extensively detailed in the current literature.
Research
Clinical Evidence
Insufficient-data confidenceN/A
Transparency
Dusting Analysis
Decursinol is primarily researched and utilized in the context of oral supplements for systemic health or in biomedical studies. There is no indication from the provided data that it is commonly used or 'dusted' in cosmetic formulations, as its topical efficacy and appropriate concentration for skin benefits are not established.
The Formula
Formulation
Stability
Decursinol (DOH) has demonstrated stability in human plasma across various storage conditions, including room temperature for 8 hours, after three freeze-thaw cycles, and during frozen storage. However, specific optimal pH ranges for stability in cosmetic formulations are not reported. The low water solubility observed for related pyranocoumarins (decursin and decursinol angelate) suggests similar formulation challenges for Decursinol in aqueous systems.
Safety
Safety Profile
Decursinol has not undergone specific safety assessments by the Cosmetic Ingredient Review (CIR) or the Scientific Committee on Consumer Safety (SCCS) for its use as a cosmetic ingredient. While the FDA does not list Decursinol as a prohibited or restricted cosmetic ingredient, this does not imply a formal review or approval for topical cosmetic use. Oral toxicology studies of a Decursinol-containing extract (Decursinol-50™) in rats indicated an LD50 of 3,722 mg/Kg for males and 2,804 mg/Kg for females, with a non-toxic dose level above 100 mg/Kg, suggesting suitability for oral consumption. However, these findings do not directly extrapolate to topical application safety or potential sensitization risks in cosmetic formulations.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Decursinol exhibits promising neuroprotective and antioxidant properties in preclinical and cellular models, but comprehensive data on its direct topical efficacy, mechanism of action, and safety for human skin in cosmetic applications is currently lacking.
Related
Similar Ingredients
Finding similar ingredients…